Easing the Disease Burden of Patients with Atopic Dermatitis: Recent Episodes
Annenberg Center for Health Sciences
Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to
- JAK-STAT inhibitors: oral and topical
- JAK-STAT inhibitors vs dupilumab
- IL-13 antagonists
- IL-31 antagonists
- 2014 AAD Guidelines
- Recommendations for topical therapies
- Recommendations for phototherapy
- Direct and indirect effects of AD
- Discordance in disease burden between providers and patients
- Rates of inadequate disease control